Kardiogen Plus: A Smarter Way to Predict and Prevent Coronary Artery Disease

Heart disease rarely strikes without warning. Long before symptoms appear, risk begins to build silently—often driven by a complex interplay of genetics and lifestyle. Yet, traditional risk assessment tools largely focus on parameters like age, cholesterol, blood pressure, etc and missing a crucial piece of the puzzle: genetic predisposition.

This is where Kardiogen Plus marks a significant shift in how we approach coronary artery disease (CAD) prediction and prevention.

Introducing Kardiogen Plus

Kardiogen Plus is an advanced predictive screening test that integrates genomic risk assessment with clinical risk factors to deliver a more comprehensive evaluation of an individual’s risk for coronary artery disease.

Offered under the Genessense genomic wellness portfolio, Kardiogen Plus empowers individuals and clinicians to move from reactive care to proactive, preventive heart health management.

The Power of Integrated Risk Prediction

What sets Kardiogen Plus apart is its ability to combine:

• Polygenic Risk Score (PRS): Assessing inherited genetic susceptibility to CAD
• Clinical risk factors: Including age, lifestyle, and other established parameters

This integrated approach allows for earlier and more accurate risk stratification, even in individuals who may appear clinically healthy today.

Who Can Benefit from Kardiogen Plus?

Kardiogen Plus is particularly valuable for:

• Individuals with a family history of heart disease
• Adults seeking preventive health insights
• People with lifestyle-related risk factors
• aged above 40 years with lifestyle-related risk factors.
• Clinicians aiming to personalize preventive strategies
• Health-conscious individuals who want to act before symptoms arise

Importantly, genetic risk remains constant throughout life—making early assessment a powerful tool for long-term prevention.

From Risk Awareness to Actionable Prevention

The insights from Kardiogen Plus go beyond risk identification. By understanding both genetic and clinical risk, clinicians can:

• Initiate earlier lifestyle interventions
• Personalize monitoring and follow-up strategies
• Guide timely preventive therapies when needed
• Improve patient engagement through data-driven discussions

For individuals, this means clarity, confidence, and the ability to take control of heart health before irreversible damage occurs.

Genessense: Empowering Wellness with Genomics

Kardiogen Plus is part of Genessense’s mission to redefine preventive healthcare through genomics. By bringing advanced genetic insights into everyday clinical practice, Genessense enables a future where disease prevention starts at the source—our DNA.

Start from the Source

Heart disease prevention should not begin after the first event. With Kardiogen Plus, risk assessment becomes earlier, deeper, and more personalized helping shift the focus from treatment to prevention.

Know your risk. Act early. Protect your heart.

Because when it comes to heart health, the smartest step is to start from the source.

Reach out to us at:
www.genessense.com | youfirst@genessense.com | 1800 296 9696